Uzan C

No ORCID on file · 11 papers in corpus · active 2004-2022

Study types

  • article 4
  • other 1
  • review 1

Condition tags

  • endometriosis 5
  • bowel_endometriosis 1
2022
Cells ·doi:10.3390/cells11111836

This systematic review of literature highlights the different microRNAs circulating in the serum or plasma of endometrial cancer patients and their association with clinical and prognostic characteristics in endometrial cancer. This study a…

2022
Journal of clinical medicine ·doi:10.3390/jcm11226765

Our aim was to assess the opinion of a panel of experts and obtain a consensus on the management of endometrial cancer in France and French Switzerland. A Delphi survey was carried out among a panel of French and French-speaking Swiss exper…

review 2019
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.12.004

OBJECTIVES: To study the methods and strategies of fertility preservation in young women with stage I epithelial ovarian cancer (EOC), in order to provide recommendations for clinical practice. METHODS: The PubMed database was searched for…

2019
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2019.04.014
2018
Journal of translational medicine ·doi:10.1186/s12967-018-1515-6

BackgroundActual European pathological classification of early-stage endometrial cancer (EC) may show insufficient accuracy to precisely stratify recurrence risk, leading to potential over or under treatment. Micro-RNAs are post-transcripti…

2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.06.008

ObjectiveTo determine the long-term outcomes of patients with an isolated ovarian recurrence after fertility sparing surgery (FSS) for epithelial ovarian cancer (EOC) and to evaluate the recurrence rates (and location) according to the new …

article 2012
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0b013e3182534acf

BackgroundThe clear cell borderline ovarian tumor (CCBOT) of the ovary is a rare tumor accounting for less than 1% of BOT. Fewer than 25 cases have been reported in the literature (including details on clinical management and outcomes). The…

other 2009
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-009-0755-5

A role for the EGF system, in particular HER1 and 2, in growth of the endometrium has been suggested but HER1 and 2 have not been studied in all locations of endometriosis and in ovarian endometrioid adenocarcinoma (OEC) which is a rare for…

article 2005
Journal of reproductive immunology ·doi:10.1016/j.jri.2004.09.002

BackgroundEndometriosis is defined by the presence of endometrium outside the uterus. Changes in the expression of the proto-oncogene c-kit are associated with aggressive behaviour of both benign and malignant tumours, but there are few dat…

article 2005
Journal of reproductive immunology ·doi:10.1016/j.jri.2005.11.003

Endometriosis is defined as the presence of endometrial glands and stroma outside the uterus. Apoptosis, a physiological process by which multicellular organisms eliminate superfluous cells, is altered in tumor tissue. Here we studied the e…

article 2004
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-004-1117-y

Endometriosis is subsequent to the ability of endometrial glands to invade normal tissues. Matrix metalloproteinases (MMPs)--enzymes that mediate normal tissue turnover, including endometrial breakdown during menstruation-appear to be invol…